Holen Sie sich die Stockscreener-App
2.65
1.92%
0.05
Schlusskurs vom Vortag:
$2.60
Offen:
$2.68
24-Stunden-Volumen:
26,670
Relative Volume:
0.05
Marktkapitalisierung:
$4.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.42M
KGV:
-1.4402
EPS:
-1.84
Netto-Cashflow:
$-13.41M
1W Leistung:
+22.69%
1M Leistung:
+5.58%
6M Leistung:
+704.25%
1J Leistung:
+165.00%
1-Tages-Spanne:
$2.50
$2.68
1-Wochen-Bereich:
$2.12
$2.9355
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Vergleichen Sie INDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
2.65 | 4.55M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Indaptus Therapeutics (NASDAQ:INDP) Downgraded by Wall Street Zen to “Sell” - Defense World
How buybacks impact Indaptus Therapeutics Inc. stock valuePortfolio Growth Summary & Real-Time Buy Signal Notifications - BỘ NỘI VỤ
Indaptus Therapeutics (NASDAQ:INDP) Rating Increased to Hold at Wall Street Zen - Defense World
Pullback Watch: How buybacks impact Indaptus Therapeutics Inc. stock valueMarket Weekly Review & Risk Controlled Stock Pick Alerts - moha.gov.vn
Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Nuvalent (NUVL) Receives a New Rating from Truist Financial - The Globe and Mail
Indaptus Therapeutics (INDP) Price Target Decreased by 60.00% to 10.20 - MSN
Volume spikes in Indaptus Therapeutics Inc. stock – what they meanEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Why Indaptus Therapeutics Inc. stock could see breakout soonPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Will Indaptus Therapeutics Inc. rebound enough to break evenJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
How high can Indaptus Therapeutics Inc. stock go2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What momentum indicators show for Indaptus Therapeutics Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
Indaptus Therapeutics 3Q Research and Development Expenses About $1.52M >INDP - 富途牛牛
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - The Manila Times
Why Is Indaptus Therapeutics, Inc. (INDP) Stock Down Today? - Meyka
Indaptus (Nasdaq: INDP) showcases Decoy20 to tackle donor cell variability - Stock Titan
Volatility clustering patterns for Indaptus Therapeutics Inc.Weekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Does Indaptus Therapeutics Inc. fit your quant trading modelJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
Why retail investors pile into Indaptus Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Can Indaptus Therapeutics Inc. stock double in next 5 yearsSwing Trade & Expert Curated Trade Setups - newser.com
Is Indaptus Therapeutics Inc. stock ready for a breakoutWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Key resistance and support levels for Indaptus Therapeutics Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com
Is Indaptus Therapeutics Inc. stock a defensive play in 2025Insider Buying & AI Forecasted Stock Moves - Fundação Cultural do Pará
Visual trend scoring systems applied to Indaptus Therapeutics Inc.July 2025 Summary & Precise Trade Entry Recommendations - newser.com
Indaptus Therapeutics Reports Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Indaptus Therapeutics Q3 profit beats estimates - MarketScreener
Indaptus Therapeutics Q3 2025 Financial Results and Corporate Update - TradingView
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Indaptus Therapeutics, Inc. Quarterly Earnings Report | INDP SEC FilingForm 10-Q - Stock Titan
[8-K] Indaptus Therapeutics, Inc. Reports Material Event | INDP SEC FilingForm 8-K - Stock Titan
Indaptus (NASDAQ: INDP) completes Decoy20 safety lead-in; $5.8M cash, runway to Q1 2026 - Stock Titan
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):